Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-12

Clinical Trial Update: Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers [NA]

View source ↗

Summary

Clinical trial evaluating noncombustible nicotine delivery systems as potential harm reduction tools for persistent cigarette smokers. Sponsor: Abramson Cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: E-cigarette Use, Cigarette Smoking | NA | Status: RECRUITING